Clinical Trial Update: A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain [Phase 2]

View source ↗

Summary

Phase 2 trial update of abemaciclib in participants with brain-metastatic breast cancer, non-small cell lung cancer, or melanoma; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Melanoma
• Non-small Cell Lung Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer, Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-12-19